Literature DB >> 21855554

The contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failure.

Pamela Harding1, David B Murray.   

Abstract

Although the role of Cox-2 in the heart's response to physiologic stress remains controversial (i.e. expression in myocytes versus other resident myocardial cells) the ever expanding role of prostanoids in multiple models of heart failure cannot be denied. Due to the fact that prostanoids are metabolized rather quickly (half life of seconds to minutes) it is believed these signaling mediators act in a paracrine fashion at the site of production. Evidence to date is quite convincing that these bioactive lipid derivatives are involved in physiologic homeostatic regulation as well as beneficial and maladaptive ventricular remodeling in heart failure. Thus, this review will assess the direct contribution of each PG on remodeling in the left ventricle (e.g. hypertrophy, functional effects, and fibrosis).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855554      PMCID: PMC3768284          DOI: 10.1016/j.lfs.2011.07.025

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  78 in total

1.  Secretion of lipocalin-type prostaglandin D synthase (beta-trace) from human heart to plasma during coronary circulation.

Authors:  Y Urade; Y Eguchi; N Eguchi; Y Kijima; Y Matsuura; H Oda; K Seiki; O Hayaishi
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Sequential induction of prostaglandin E and D synthases in inflammation.

Authors:  Rufina Schuligoi; Magdalena Grill; Akos Heinemann; Bernhard A Peskar; Rainer Amann
Journal:  Biochem Biophys Res Commun       Date:  2005-09-30       Impact factor: 3.575

3.  Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury.

Authors:  Melanie Martin; Jutta Meyer-Kirchrath; Gernot Kaber; Christoph Jacoby; Ulrich Flögel; Jürgen Schrader; Ulrich Rüther; Karsten Schrör; Thomas Hohlfeld
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

4.  FP-receptor mediated trophic effects of prostanoids in rat ventricular cardiomyocytes.

Authors:  K Pönicke; C Giessler; M Grapow; I Heinroth-Hoffmann; K Becker; B Osten; O E Brodde
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2).

Authors:  Mónica B Frungieri; Martin Albrecht; Romi Raemsch; Artur Mayerhofer
Journal:  Cell Signal       Date:  2005-04       Impact factor: 4.315

6.  Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes.

Authors:  J W Adams; V P Sah; S A Henderson; J H Brown
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

7.  Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

Authors:  Takuya Kobayashi; Yoshio Tahara; Mayumi Matsumoto; Masako Iguchi; Hideto Sano; Toshinori Murayama; Hidenori Arai; Hiroji Oida; Takami Yurugi-Kobayashi; Jun K Yamashita; Hiroyuki Katagiri; Masataka Majima; Masayuki Yokode; Toru Kita; Shuh Narumiya
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.

Authors:  Takehiro Ogata; Takashi Miyauchi; Satoshi Sakai; Masakatsu Takanashi; Yoko Irukayama-Tomobe; Iwao Yamaguchi
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

Review 9.  The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

Authors:  R Pettipher
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

10.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disorders.

Authors:  Mónica B Frungieri; Stephan Weidinger; Viktor Meineke; Frank M Köhn; Artur Mayerhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

View more
  6 in total

1.  PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.

Authors:  Peter Tzu-Yu Chien; Hsi-Lung Hsieh; Pei-Ling Chi; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

2.  Prostaglandin E2 in remote control of myocardial remodeling.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Circulation       Date:  2012-05-15       Impact factor: 29.690

3.  Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway.

Authors:  Yun Chen; Shengju Yang; Wenjuan Yao; Hongyan Zhu; Xiaole Xu; Guoliang Meng; Wei Zhang
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

4.  A high-throughput and untargeted lipidomics approach reveals new mechanistic insight and the effects of salvianolic acid B on the metabolic profiles in coronary heart disease rats using ultra-performance liquid chromatography with mass spectrometry.

Authors:  Ying-Peng Li; Cong-Ying Wang; Hong-Tao Shang; Rui-Rui Hu; Hui Fu; Xue-Feng Xiao
Journal:  RSC Adv       Date:  2020-05-01       Impact factor: 4.036

5.  Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.

Authors:  Hong-Min Zhou; Ming-Li Zhong; Yan-Fang Zhang; Wen-Yu Cui; Chao-Liang Long; Hai Wang
Journal:  Int J Mol Med       Date:  2014-09-12       Impact factor: 4.101

Review 6.  Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.

Authors:  Vincent F M Segers; Dirk L Brutsaert; Gilles W De Keulenaer
Journal:  Front Physiol       Date:  2018-04-11       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.